Show simple item record

dc.contributor.authorPérez Arana, Gonzalo Martín 
dc.contributor.authorDíaz Gómez, Alfredo Luis 
dc.contributor.authorBancalero-de los Reyes, José
dc.contributor.authorCamacho Ramírez, Alonso
dc.contributor.authorFernández Vivero, José 
dc.contributor.authorRibelles García, Antonio 
dc.contributor.authorAlmorza Gomar, David 
dc.contributor.authorCarrasco Molinillo, María del Carmen 
dc.contributor.authorMateo-Gavira, Isabel
dc.contributor.authorPrada Oliveira, José Arturo 
dc.contributor.otherAnatomía y Embriología Humanaes_ES
dc.contributor.otherEstadística e Investigación Operativaes_ES
dc.date.accessioned2021-12-02T08:08:32Z
dc.date.available2021-12-02T08:08:32Z
dc.date.issued2021-11
dc.identifier.issn1618-0402
dc.identifier.urihttp://hdl.handle.net/10498/25823
dc.description.abstractBACKGROUND: Roux-en-Y gastric bypass (RYGB) is the gold standard method for bariatric surgery and leads to substantial improvements in Type 2 Diabetes mellitus. However, many patients experience relapses in diabetes five years after undergoing this aggressive surgical procedure. We focus on beta-cell population changes and absorptive intestinal consequences after RYGB in a healthy nonobese animal model after a long survival period. METHODS: For our purpose, we use three groups of Wistar rats: RYGB-operated, surgical control (Sham) and fasting control. We measure alpha-, beta-cell mass; transcription (Arx, and Pdx-1) and proliferation (Ki67) factors; glucose tolerance and insulin release after oral glucose tests; histological adaptive changes in the jejunum; and intestinal glucose transporters. RESULTS: Our results showed an early increase in insulin secretion after surgery, that decrease at the end of the study. The beta-cell mass reduces twenty-four weeks after RYGB, which coincides with decrease of Pdx-1 transcription promoter factor. These was coincident with an increase in alpha-mass and a high expression of Arx in RYGB group. CONCLUSIONS: The analysis of all data showed beta-cell mass transdifferentiation into alpha-cell mass in RYGB rats. Due to long-term exhaustion of the beta-cell population by hyperinsulinism derived from digestive tract adaptation to surgery. Copyright © 2021 The Author(s). Published by Elsevier GmbH.. All rights reserved.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherELSEVIERes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceAnnals of Anatomy 240 (2021) 151855es_ES
dc.subjectAlpha-Cellses_ES
dc.subjectBeta-Cell masses_ES
dc.subjectPancreases_ES
dc.subjectType 2 Diabetes mellituses_ES
dc.subjectRoux-en Y-gastric bypasses_ES
dc.subjectIncretinses_ES
dc.subjectCellular differentiationes_ES
dc.titleThe long-term failure of RYGB surgery in improving T2DM is related to hyperinsulinism.es_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1016/j.aanat.2021.151855


Files in this item

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
This work is under a Creative Commons License Attribution-NonCommercial-NoDerivatives 4.0 Internacional